BeInCrypto·

COVID Vaccine Giant AstraZeneca Stock Jumps 7%. What's Behind It?

Your call?

AstraZeneca Q3 earnings beat forecasts as the drugmaker launches a $1.5 billion savings plan to fund its AI-backed pipeline.

Share

More news